Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/308110
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Andreu, Sabina | es_ES |
dc.contributor.author | Ripa, Inés | es_ES |
dc.contributor.author | Bello-Morales, Raquel | es_ES |
dc.contributor.author | López-Guerrero, José Antonio | es_ES |
dc.date.accessioned | 2023-05-04T09:38:12Z | - |
dc.date.available | 2023-05-04T09:38:12Z | - |
dc.date.issued | 2023-04-15 | - |
dc.identifier.citation | Viruses 15(4): 972 (2023) | es_ES |
dc.identifier.uri | http://hdl.handle.net/10261/308110 | - |
dc.description.abstract | A limited number of effective therapies are currently available to treat human coronavirus SARS-CoV-2 and other human coronaviruses, which are responsible for nearly a third of global cases of the common cold. The possibility of new emerging coronaviruses demands powerful new antiviral strategies. Lactoferrin is a well-known protein that possesses anti-inflammatory and immunomodulatory activities, and it has previously shown antiviral activity against several viruses, including SARS-CoV-2. To increase this antiviral activity, here we present bovine liposomal lactoferrin. Liposomal encapsulation of the compound was proven to increase permeability, bioavailability, and time release. In the present work, we compare the antiviral activity of free and liposomal bovine lactoferrin against HCoV229E and SARS-CoV-2 in vitro and in human primary bronchial epithelial cells, and we demonstrated that the liposomal form exerts a more potent antiviral activity than its free form at non-cytotoxic doses. | es_ES |
dc.format | application/pdf | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Multidisciplinary Digital Publishing Institute | es_ES |
dc.relation.isversionof | Publisher's version | es_ES |
dc.rights | openAccess | es_ES |
dc.subject | Lactoferrin | es_ES |
dc.subject | Liposomal lactoferrin | es_ES |
dc.subject | Antivirals | es_ES |
dc.subject | SARS-CoV-2 | es_ES |
dc.subject | COVID-19 | es_ES |
dc.title | Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.3390/v15040972 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | https://doi.org/10.3390/v15040972 | es_ES |
dc.identifier.e-issn | 1999-4915 | - |
dc.date.updated | 2023-05-04T09:38:12Z | - |
dc.rights.license | http://creativecommons.org/licenses/by/4.0/ | es_ES |
dc.relation.csic | Sí | es_ES |
dc.contributor.orcid | Andreu, Sabina [0000-0003-0600-4152] | es_ES |
dc.contributor.orcid | Ripa, Inés [0000-0001-7007-5401] | es_ES |
dc.contributor.orcid | Bello-Morales, Raquel [0000-0002-4415-6483] | es_ES |
dc.contributor.orcid | López-Guerrero, José Antonio [0000-0003-2817-5956] | es_ES |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
item.openairetype | artículo | - |
Aparece en las colecciones: | (CBM) Artículos (PTI Salud Global) Colección Especial COVID-19 |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
viruses-15-00972-v2.pdf | 1,66 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
2
checked on 15-may-2024
WEB OF SCIENCETM
Citations
2
checked on 21-feb-2024
Page view(s)
44
checked on 21-may-2024
Download(s)
84
checked on 21-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons